Link-Asia International Medtech Group Ltd. (HK:1143)
:1143
Top Page
Link-Asia International Medtech Group Ltd.
(1143)
Select Model
Select Model
Rating:45Neutral
Price Target:
HK$0.38
▲(0.00% Upside)
Action:ReiteratedDate:01/22/26
The score is primarily constrained by weak financial performance—declining revenues, volatile profitability, and inconsistent operating/free cash flow—partly offset by a comparatively steadier balance sheet. Technical signals are mixed without strong momentum, and valuation is penalized by a negative P/E with no dividend support.
Positive Factors
Diversified revenue streams and partnerships
Link-Asia's multi-channel revenue model and stated focus on partnerships and R&D collaborations create durable revenue diversification. Multiple sales routes and potential licensing reduce single-customer risk and support steadier cash conversion as new products scale over months to years.
Negative Factors
Sustained revenue decline
A persistent downward revenue trend erodes scale benefits and limits ability to leverage fixed-cost absorption. Continued top-line contraction over multiple years raises structural questions about market position, product competitiveness, and the viability of long-term growth plans.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified revenue streams and partnerships
Link-Asia's multi-channel revenue model and stated focus on partnerships and R&D collaborations create durable revenue diversification. Multiple sales routes and potential licensing reduce single-customer risk and support steadier cash conversion as new products scale over months to years.
Read all positive factors
Link-Asia International Medtech Group Ltd. (1143) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$86.35M
Dividend YieldN/A
Average Volume (3M)1.09M
Price to Earnings (P/E)―
Beta (1Y)0.57
Revenue Growth-25.16%
EPS Growth-160.31%
CountryHK
Employees835
SectorTechnology
Sector Strength88
IndustryConsumer Electronics
Share Statistics
EPS (TTM)-0.13
Shares Outstanding224,289,180
10 Day Avg. Volume1,292,540
30 Day Avg. Volume1,091,788
Financial Highlights & Ratios
PEG Ratio0.29
Price to Book (P/B)0.13
Price to Sales (P/S)0.14
P/FCF Ratio-0.89
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Link-Asia International Medtech Group Ltd. Business Overview & Revenue Model
Company Description
Link-Asia International MedTech Group Limited, an investment holding company, provides electronic manufacturing services (EMS) for the telecommunications, security, car electronics, home appliances, other consumer, and industrial electronic produc...
How the Company Makes Money
Link-Asia International Medtech Group Ltd. generates revenue through multiple streams, primarily by selling its medical devices and technologies to healthcare providers, hospitals, and clinics. The company's revenue model is centered around direct...
Link-Asia International Medtech Group Ltd. Financial Statement Overview
Summary
Income Statement
45
Neutral
Balance Sheet
55
Neutral
Cash Flow
40
Negative
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 402.85M | 479.32M | 502.00M | 529.25M | 675.52M | 595.02M |
| Gross Profit | 90.89M | 123.60M | 136.87M | 101.40M | 144.89M | 154.71M |
| EBITDA | 14.14M | 4.78M | 40.49M | -14.06M | -4.54M | -116.52M |
| Net Income | -4.33M | 8.04M | 5.26M | -54.04M | -46.40M | -173.05M |
Balance Sheet | ||||||
| Total Assets | 875.18M | 880.14M | 776.42M | 659.23M | 677.98M | 657.40M |
| Cash, Cash Equivalents and Short-Term Investments | 331.35M | 312.05M | 271.57M | 252.21M | 146.80M | 167.66M |
| Total Debt | 94.77M | 86.60M | 26.75M | 51.08M | 61.20M | 70.19M |
| Total Liabilities | 343.00M | 343.25M | 287.69M | 297.22M | 311.98M | 361.47M |
| Stockholders Equity | 532.05M | 536.53M | 486.66M | 359.86M | 365.88M | 295.46M |
Cash Flow | ||||||
| Free Cash Flow | -47.91M | -75.67M | -132.09M | 99.60M | -122.55M | -45.85M |
| Operating Cash Flow | -43.60M | -73.19M | -129.29M | 107.55M | -100.45M | -15.04M |
| Investing Cash Flow | 15.74M | 49.83M | 48.86M | 2.13M | 3.31M | -96.19M |
| Financing Cash Flow | 55.49M | 66.31M | 101.84M | 4.68M | 74.19M | 35.17M |
Link-Asia International Medtech Group Ltd. Technical Analysis
Negative
0.38
Price Trends
0.39
Negative
0.39
Negative
0.40
Negative
Market Momentum
>-0.01
Positive
34.10
Neutral
23.19
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1143, the sentiment is Negative. The current price of 0.38 is below the 20-day moving average (MA) of 0.39, below the 50-day MA of 0.39, and below the 200-day MA of 0.40, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 34.10 is Neutral, neither overbought nor oversold. The STOCH value of 23.19 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1143.
Link-Asia International Medtech Group Ltd. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
52 Neutral | HK$58.32M | -1.47 | -216.50% | ― | -35.77% | -1.06% | |
45 Neutral | HK$86.35M | -1.29 | -0.81% | ― | -25.16% | -160.31% | |
41 Neutral | HK$159.57M | -16.53 | 18.06% | ― | 21.86% | ― | |
39 Underperform | HK$36.09M | -10.94 | 80.51% | ― | -0.76% | 93.44% |
* Technology Sector Average
HK:1143
Link-Asia International Medtech Group Ltd.
0.39
0.09
30.51%
HK:0328
Alco Holdings
0.63
-0.35
-35.71%
HK:0110
China Fortune Holdings Limited
0.23
0.10
72.93%
HK:8147
Millennium Pacific Group Holdings Ltd
0.77
0.48
165.52%
Link-Asia International Medtech Group Ltd. Corporate Events
China Energy Storage Technology Development Halts Trading Ahead of Takeover-Related Announcement
Jan 22, 2026
China Energy Storage Technology Development Limited has requested a halt in trading of its shares on the Main Board of the Hong Kong Stock Exchange, effective from 9:00 a.m. on 22 January 2026. The suspension comes ahead of an upcoming announcemen...
China Energy Storage Technology Development Appoints New Co-Chairman
Dec 16, 2025
China Energy Storage Technology Development Limited, formerly known as Link-Asia International MedTech Group Ltd., has announced the appointment of Mr. Wang Wei as an executive Director and Co-Chairman, effective December 16, 2025. Mr. Wang, with ...
China Energy Storage Technology Development Limited Announces Board Composition
Dec 16, 2025
China Energy Storage Technology Development Limited, formerly known as Link-Asia International MedTech Group Ltd., has announced the composition of its board of directors. The board includes both executive and independent non-executive directors, ...
China Energy Storage Technology Announces Change in Substantial Shareholder
Dec 12, 2025
China Energy Storage Technology Development Limited has announced a change in its substantial shareholder structure. Mr. Chen Dezhu, a major shareholder, has sold his 23.1% stake in the company to Fame Castle Enterprises Limited, which is owned by...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.